Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism : a case report
ID
Kozak, Matija
(
Author
),
ID
Vižintin Cuderman, Tjaša
(
Author
),
ID
Božič Mijovski, Mojca
(
Author
),
ID
Lučovnik, Miha
(
Author
),
ID
Miklič, Marko
(
Author
),
ID
Tratar, Gregor
(
Author
),
ID
Rojnik, Tamara
(
Author
)
PDF - Presentation file,
Download
(1,54 MB)
MD5: 4327F2B63CFD501A5F49F1D30D6B9AE4
URL - Source URL, Visit
https://link.springer.com/article/10.1186/s12959-025-00775-z
Image galllery
Abstract
Background: Antithrombin deficiency (ATD) in pregnant patients significantly increases the risk of venous thromboembolism (VTE), but guidelines for managing anticoagulation during pregnancy, labour, and postpartum in patients with ATD are limited. Case presentation: A pregnant woman with ATD suffered recurrent VTE in the 20th week of pregnancy despite therapeutic doses of low-molecular-weight heparin (LMWH). The acute VTE was treated with argatroban and then with warfarin until delivery. LMWH with antithrombin (AT) concentrate was introduced before and shortly after delivery, followed by warfarin, which was continued also postpartum. No further complications occurred during the remainder of pregnancy, delivery, and two-year follow-up. Conclusion: Our case highlights the challenges of anticoagulant treatment in pregnant patients with ATD. Standard weight-based LMWH dosing can lead to inadequate anticoagulation, as demonstrated by an acute VTE event in our patient. In our case, the use of argatroban proved to be safe and effective in the acute setting, followed by warfarin in the 2nd and 3rd trimester, and subsequent co-administration of LMWH and AT concentrate before and after delivery. Concomitant use of LMWH and AT concentrate allows for achieving target anti-Xa levels. Measurement of both anti-Xa and AT activity is advisable in this scenario to ensure reliable anticoagulant management. ATD is a heterogeneous disorder; therefore, each successfully managed pregnancy advances clinical practice.
Language:
English
Keywords:
anticoagulants
,
antithrombin III
,
case report
,
pregnancy
,
venous thromboembolism
Work type:
Article
Typology:
1.03 - Other scientific articles
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
6 str.
Numbering:
Vol. 23, arti. 94
PID:
20.500.12556/RUL-187791
UDC:
616.1:618.3
ISSN on article:
1477-9560
DOI:
10.1186/s12959-025-00775-z
COBISS.SI-ID:
252391171
Publication date in RUL:
14.09.2026
Views:
104
Downloads:
20
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Thrombosis journal
Shortened title:
Thromb J
Publisher:
Springer Nature
ISSN:
1477-9560
COBISS.SI-ID:
2611220
Licences
License:
CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:
The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0308
Name:
Ateroskleroza in tromboza
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back